Trial Profile
TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia, a multicenter, open-label, non-randomized, controlled study (TOPIC-3 study).
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- Acronyms TOPIC-3
- 14 Aug 2018 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified August 2018 ).
- 14 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Nov 2016 Status changed from not yet recruiting to recruiting.